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• Ethylene glycol ingestion first affects the central nervous system 
(CNS). After a characteristic latent period, signs of inebriation may 
be followed by serious illness and even death, caused by toxic 
metabolites. 
• Propylene glycol, which is much less toxic than ethylene glycol, is 
metabolized to compounds that are normal constituents of the citric 
acid cycle.  
• No health effects have been reported in persons chronically exposed 
to ethylene glycol or propylene glycol at levels found in the 
environment. 





This educational case study document is one in a series of self-
instructional publications designed to increase the primary care 
provider’s knowledge of hazardous substances in the environment and 
to promote the adoption of medical practices that aid in the evaluation 
and care of potentially exposed patients. The complete series of Case 
Studies in Environmental Medicine is located on the ATSDR Web site at 
http://www.atsdr.cdc.gov/csem/. In addition, the downloadable PDF 
version of this educational series and other environmental medicine 
materials provides content in an electronic, printable format, especially 
for those who may lack adequate Internet service. 




See Internet address www2.cdc.gov/atsdrce/ for more information 
about continuing medical education credits, continuing nursing 
education credits, and other continuing education units. 
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How to Use This Course 
Introduction The goal of Case Studies in Environmental Medicine (CSEM) is to 
increase the primary care provider’s knowledge of hazardous 
substances in the environment and to help in evaluation and treating of 
potentially exposed patients. This CSEM focuses on ethylene glycol and 
propylene glycol toxicity. 
Available 
Versions 
Two versions of the Ethylene Glycol and Propylene Glycol Toxicity. CSEM 
are available 
• the HTML version http://www.atsdr.cdc.gov/csem/egpg/ 
provides content through the Internet; 
• the downloadable PDF version provides content in an electronic, 
printable format, especially for those who may lack adequate 
Internet service. 
The HTML version offers interactive exercises and prescriptive feedback 
to the user. 
Instructions To make the most effective use of this course, we recommend that you 
• take the Initial Check to assess your current knowledge about 
ethylene glycol and propylene glycol toxicity 
• read the title, learning objectives, text, and key points in each 
section 
• complete the progress check exercises at the end of each section 
and check your answers 
• complete and submit your assessment and posttest response online 
if you wish to obtain continuing education credit. Continuing 
education certificates can be printed immediately upon completion. 
Instructional 
Format 
This course is designed to help you learn efficiently. Topics are clearly 
labeled so that you can skip sections or quickly scan sections you are 
already familiar with. This labeling will also allow you to use this training 
material as a handy reference. To help you identify and absorb 
important content quickly, each section is structured as follows: 
 
Section Element Purpose 
Title Serves as a “focus question” that you should be able to answer after 
completing the section 
Learning Objectives Describes specific content addressed in each section and focuses your 
attention on important points 
Text Provides the information you need to answer the focus question (s) and 
achieve the learning objectives 
Key Points Highlights important issues and helps you review 
Progress Check 
exercises 
Enables you to test yourself to determine whether you have mastered 
the learning objectives 
Progress Check 
answers 
Provides feedback to ensure you understand the content and can locate 
information in the text 
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Learning 
Objectives 
Upon completion of the Ethylene Glycol and Propylene Glycol Toxicity 
CSEM, you will be able to 
 
Topic Objectives 
What is ethylene glycol? • Describe the properties of ethylene glycol 
Where is ethylene glycol 
found? 
• Identify sources of ethylene glycol exposure 
How are people exposed to 
ethylene glycol? 
• Identify the primary route of exposure to ethylene 
glycol 
What are U.S. standards for 
ethylene glycol exposure 
levels? 
• Identify the American Conference of Governmental 
Industrial Hygienists (ACGIH) ceiling exposure limit for 
ethylene glycol 
• Identify the U.S. Environmental Protection Agency’s 
(EPA) guidelines for ethylene glycol in drinking water 
What is the Biological Fate 
of ethylene glycol? 
• Describe why individuals with impaired liver function 
are more likely to suffer less toxicity but greater 
intensity of the initial central nervous system (CNS) 
effects caused by ethylene glycol exposure 
What are the stages of 
ethylene glycol intoxication? 
• Explain the mechanism of ethylene glycol toxicity 
• Describe the three stages of ethylene glycol toxicity 
What are the physiologic 
effects of ethylene glycol 
poisoning? 
• Describe the physiologic effects of ethylene glycol 
poisoning 
How should patients 
exposed to ethylene glycol 
be evaluated? 
• Describe the primary focus of the exposure history 
• Describe how the actual clinical presentation changes 
over time as intoxication evolves 
What laboratory tests can 
help in evaluating patients 
exposed to ethylene glycol? 
• Identify the abnormal laboratory findings associated 
with ethylene glycol poisoning. 
• List three measurements that can assist with 
diagnosis of ethylene glycol poisoning 
How should patients 
exposed to ethylene glycol 
be treated? 
• Identify the primary treatment strategy for managing 
ethylene glycol poisoning case 
What is propylene glycol? • Describe the properties and uses of propylene glycol 
What instructions should be 
given to patients? 
• Explain advice on self care and follow-up care to 
patients who are exposed to ethylene glycol or 
propylene glycol 
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Initial Check 
Instructions This Initial Check will help you assess your current knowledge about 
ethylene glycol toxicity. To take the Initial Check, read the case below 
and then answer the questions that follow. 
Case Study, 
First Patient 
Disorientation, Ataxia, and Abdominal Symptoms in Visitors to a 
Municipal Airport  
 A 67-year-old man is brought to the Emergency Department (ED) of a 
small community hospital where you are the family physician on call. 
The patient is experiencing ataxia, dizziness, and vomiting. He is 
hyperventilating. On physical examination, the patient appears well 
nourished, but agitated and disoriented. There is no odor of ethanol on 
his breath.  
Vital Signs 
The patient’s vital signs are 
• blood pressure (BP): 120/80 mm Hg 
• temperature: 98.5° F 
• pulse: 80 beats/minute 
• respirations: 40 breaths/minute 
Neurologic examination is otherwise normal with no crucial findings. 
There is no nystagmus. Abdominal and cardiorespiratory examinations 
are also normal. 
Additional Information 
The patient’s friend brought him to the ED. The friend said the patient 
complained of dizziness and had begun to vomit late last night. This 
morning the patient was hyperventilating and continued to vomit. Both 
men are retired pilots who teach at the local airport’s ground school. 
Because two other people had collapsed at the airport that morning and 
were taken by ambulance to another hospital, the friend wonders if the 
food at the airport cafeteria is responsible. Both he and the patient had 
hot dogs and coleslaw, but the friend states that he feels fine. 
Results of Lab Tests 
• blood ethanol and drug screen are negative 
• arterial blood gases (ABG) results: pH 7.10; PaCO2=20 mm Hg; 
PaO2 =95 mm Hg; and Bicarbonate, =8 mEq/L 
• sodium: 145 mmol/L (normal 135-145 mmol/L (Jacobs DS 1996)) 
• potassium: 3.8 mmol/L (normal 3.1-5.3 mmol/L) 
• chloride: 105 mEq/L ( normal 98-109 mEq/L) 
• BUN: 20 mg/dL (normal 8-18 mg/dL) 
• creatinine: 1.0 mg/dl (normal 0.6-1.2 mg/dL) 
• glucose: 80 mg/dl ( normal 65-110 mg/dL) 
• calculated anion gap: 32 (normal 12 to 16) 
Normal values may vary from lab to lab and depend upon the elevation 
above sea level. 
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Arterial blood gases (at sea level and breathing room air)  
Partial pressure of oxygen (PaO2) 70–100 millimeters of mercury (mm Hg) 
Partial pressure of carbon dioxide 
(PaCO2) 
35–45 mm Hg 
pH 7.35–7.44 
Bicarbonate (HCO-3) 21–28 milliequivalents per liter (mEq/L) 
Oxygen content (O2CT) 15%–23% (15–23 milliliters [mL] per 100 mL of 
blood) 





Less than 30 minutes later, a 4-year-old boy is brought to the ED. On 
examination you find a sleepy but arousable child. There is no evidence 
of trauma or focal neurologic signs. Abdominal and cardiorespiratory 
examinations are normal. 
Vital Signs 
The patient’s vital signs are 
• BP, 94/76 mm Hg  
• rectal temperature: 98.5° F 
• respirations: 12 breaths/minute 
• pulse: 78 beats/minute 
Additional Information 
The parents tell you they were attending a local fliers’ club luncheon at 
the airport. When they found the child staggering and incoherent, they 
rushed him to the emergency room. On the way, he vomited in the car. 
Results of Lab Tests 
You order the same laboratory tests for the child that you ordered for 
the 67-year-old patient. The tests reveal that the child is 
• hypoglycemic 
• has slight acidosis 
• an anion gap of 13 
Additional Information 
You contact the local health department. You are told they are 
investigating the earlier incidents at the airport. They suspect the 
airport’s water supply is contaminated, but they have not identified the 
contaminant. 
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1. What would you include in the list of problems for each patient? 




2. What additional tests, if any, will you order for these patients? 
3. How will you initially treat these patients? 
4. What questions would health department investigators ask airport 
visitors and employees to establish the exposure source? 
5. The health department identifies the water contaminant as ethylene 
glycol. When construction crews at the airport were repairing the 
water supply system, they inadvertently connected the water from 
the heating system to the drinking water system. The concentration 
of ethylene glycol measured at the cafeteria’s water source was 9% 
(90,000 ppm). The US Environmental Protection Agency (EPA) has 
an ethylene glycol drinking water quality guideline of 7 ppm  
(FSTRAC 1990). The lethal dose of 95% ethylene glycol is about 100 
ml for an adult or 1.4 ml/kg.  
Who in the case study may be at risk of adverse health effects? 
Explain. 
6. A week after the water contamination incident, a patient comes to 
your office. He de-ices airplanes at the airport and was drenched 
with de-icing fluid in a major spill yesterday. He knows that de-icing 
agents contain large amounts of ethylene glycol. He immediately 
showered and changed clothes after the incident, but he is worried 
about possible adverse health effects; for example, he wonders if 
cancer could develop. What will you tell him? 
7. A pregnant worker at the airport consults you because she drank tea 
brewed with the contaminated water. Although she consumed only a 
small amount of tea and had no ill effects, she is worried that her 
fetus will be adversely affected. How will you counsel her? 
8. It was later determined that during dinner at the cafeteria, the 67-
year-old man had consumed several cups of coffee, while his friend, 
who did not become ill, drank only soda from a can. The serum 
ethylene glycol level for the 67-year-old patient is 55 mg/dl; the 
anion gap is 35. How will you treat the 67-year-old patient?  
9. The child’s ethanol level is 85 mg/dl. You repeat the ethanol test, 
and again the result is high. The parents are incredulous but admit 
that the child was not supervised closely during the luncheon, where 
wine and cocktails were served. Potential ethylene glycol exposure 
sources for the child could not be identified. How will you treat the 
child? 
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• elevated anion-gap metabolic acidosis 
The child’s medical problems include 
• somnolence 
• ataxia 
• mental status changes 
• vomiting 
• hypoglycemia 
• low body temperature 
• slight anion-gap metabolic acidosis 
 (Common toxic agents associated with an elevated anion gap are 
shown in Table 2.)  
2. Additional testing of these patients should include: 
• urinalysis 
• complete blood count 
• serum osmolality measured by the freezing-point–depression 
technique 
• ethylene glycol and methanol levels,  
• ammonia, acetaminophen, and aspirin levels, and 
• liver function tests.  
More information for this answer can be found in the section “What 
laboratory tests can help in evaluating patients exposed to ethylene 
glycol?”  
3. Several hours have passed since the ingestion, and emesis or gastric 
lavage will be of little value. Activated charcoal is likely to be 
ineffective unless there is a question of a possible overdose. It is 
important to act promptly to correct the metabolic acidosis and to 
prevent further conversion of the remaining ethylene glycol into its 
toxic metabolites. The acidosis can be corrected with sodium 
bicarbonate therapy. Intravenous administration of ethanol or 
fomepizole (as described in the Treatment and Management section) 
will inhibit further metabolism of ethylene glycol. At serum ethylene 
glycol levels of 50 mg/dl or greater, hemodialysis should be started 
to remove ethylene glycol and its metabolites from the blood. 
Pyroxidine and thiamine may also be administered.  
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The child may be intoxicated with only ethanol or with ethanol and 
ethylene glycol. If intoxication is due to ethanol alone, carefully 
monitor blood glucose and ethanol levels until the intoxication 
resolves. However, you must consider that ethylene glycol poisoning 
may be a complication. Because ethanol competitively inhibits 
ethylene glycol metabolism, you may choose to let the ethanol level 
decrease naturally to 70 mg/dl, then administer ethanol 
intravenously to maintain that level. If laboratory results indicate 
that ingestion of ethylene glycol occurred, immediately transfer the 
child to a pediatric unit to undergo hemodialysis. 
More information for this answer can be found in the section “How 
should patients exposed to ethylene glycol be treated?” 
4. The most common sources of epidemic poisonings include 
contaminated food, beverages, and water supplies. The investigators 
would ask about types of food and drink available at the airport. 
They would take a detailed history of food and beverage intake from 
the patients and all others at the airport. They would attempt to find 
a common factor that would include those who were ill and exclude 
those who did not become ill. By gathering such data from a large 
number of people and statistically analyzing the data, the exposure 
source can usually be identified or possibilities restricted. 
More information for this answer can be found in the section “Where 
is ethylene glycol found?” 
5. The lethal dose of antifreeze (95% ethylene glycol) is about 100 ml 
or 1.4 ml/kg, although there is wide variation among reported cases. 
A cup (240 ml) of the contaminated water would contain about 22 
ml of ethylene glycol. This dose could cause significant toxicity. Even 
mild symptoms of ethylene glycol poisoning would be a concern for 
air traffic controllers and other airport personnel responsible for 
judgments affecting many lives. All employees and visitors who 
consumed beverages or food that was prepared using water at the 
airport should be examined.  
More information for this answer can be found in the section “How 
are people exposed to ethylene glycol?” 
6. Absorption of ethylene glycol is minimal through intact skin and is 
not likely to lead to toxic effects. Because the patient showered and 
changed clothes immediately, it is unlikely that he will experience 
toxic effects from the spill. In the case of chronic exposure during 
the de-icing process, few particles from a spraying device are likely 
to be respirable, so inhalation of ethylene glycol would be minimal. 
Contact during the de-icing process would not contribute 
substantially to toxicity, especially if protective clothing and 
respiratory protection were used. There is no evidence that ethylene 
glycol causes cancer in humans. 
More information for this answer can be found in the section “What 
are the physiologic effects of ethylene glycol?” 
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7. You can inform the patient that studies in experimental animals 
indicate that ethylene glycol at the high, prolonged levels can cause 
developmental effects although no studies in humans specifically 
assess the effects of ethylene glycol on fetal development. 
More information for this answer can be found in the section “What 
are the physiologic effects of ethylene glycol?” 
8. Several hours have passed since the ingestion, and emesis or gastric 
lavage will be of little value. Activated charcoal is likely to be 
ineffective. However, it is important to act promptly to correct the 
metabolic acidosis and to prevent further conversion of the 
remaining ethylene glycol into its toxic metabolites. The acidosis can 
be corrected with sodium bicarbonate therapy. Intravenous 
administration of ethanol or fomepizole (as described in the 
Treatment and Management section) will inhibit further metabolism 
of ethylene glycol. At serum ethylene glycol levels of 50 mg/dl or 
greater, hemodialysis may be instituted to remove ethylene glycol 
and its metabolites from the blood. Pyroxidine and thiamine may 
also be administered. Recent studies show that even when ethylene 
glycol levels exceed 50 mg/dL, hemodialysis can be avoided and 
patients can be treated solely with fomepizole. However if the level 
exceeds 50 mg/dL and is accompanied by renal failure and severe 
metabolic acidosis, then hemodialysis is indicated. The bottom line is 
that levels of ethylene glycol per se should not determine the 
indication for dialysis, but should be considered along with the 
clinical presentation. 
More information for this answer can be found in the section “How 
should patients exposed to ethylene glycol be treated?” 
9. The child could be intoxicated with ethanol alone or with ethanol and 
ethylene glycol. If intoxication is due only to ethanol, carefully 
monitor blood glucose and ethanol until the intoxication resolves. 
However, you must consider that ethylene glycol poisoning may be a 
complication. Because ethanol competitively inhibits ethylene glycol 
metabolism, you may choose to let the ethanol level decrease 
naturally to 70 mg/dl, then administer ethanol intravenously to 
maintain that level. If laboratory results indicate that ingestion of 
ethylene glycol occurred, immediately transfer the child to a 
pediatric unit to undergo hemodialysis.  
More information for this answer can be found in the section “How 
should patients exposed to ethylene glycol be treated?” 
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What Is Ethylene Glycol? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• describe the properties of ethylene glycol. 
Definition  
 
Ethylene glycol is a clear, colorless, odorless, sweet-tasting liquid. It has 
low vapor pressures at room temperature and, therefore, low potential 
for significant inhalation exposure. 
Ethylene glycol and propylene glycol have similar physical properties and 
uses. Their chemical structures differ by only one methyl group (ethylene 
glycol, HOCH2CH2OH; propylene glycol, CH3CH[OH]CH2OH).  
Synonyms Ethylene glycol is also known as 
• ethylene alcohol 




Toxicity Route Effect 
Ingestion Ethylene glycol causes acute toxicity in humans if 
ingested 
Dermal Ethylene glycol is poorly absorbed by skin 





• dissolves in water and alcohol 
• can hold large amounts of heat before boiling 
• lowers the freezing point of water 
• absorbs twice its weight in water 
Uses  
 
Ethylene glycol is used as 
• a drying agent, 
• a component of automotive fluids such as antifreeze, coolants, and 
hydraulic fluids, 
• de-icing agents, 
• a chemical intermediate, 
• a solvent in inks, stains, pesticides, fire extinguishers, foams, 
polishes, and adhesives, and 
• a heat-transfer fluid in air conditioning units and solar energy 
systems. 
It is also used in producing polyester fibers, films, resin products, 
cosmetics, and fat extractants. 
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Air: Ethylene glycol does not persist in large amounts in ambient air 
because breakdown is rapid (half-life in air is 8-84 hours). In 
environmental exposure situations, its low vapor pressure precludes 
substantial inhalation exposure at ambient temperatures, and its poor 
skin absorption prevents significant absorption after dermal contact.  
Water: Ethylene glycol is miscible with water and will leach through soil 
to groundwater. It biodegrades rapidly in soil (half-life, 2-12 days). The 
half-life ranges from 2-12 days in surface water and 4- 24 days in 
ground water. Because it is not fat soluble and biodegrades rapidly, 
bioconcentration and bioaccumulation are insignificant (Agency for Toxic 
Substances and Disease Registry 1997).  
Key Points • Because of ethylene glycol’s low vapor pressure and poor skin 
absorption, poisonings normally occur by ingestion. 
• Ethylene glycol degrades rapidly in the environment. 
Progress 
Check 
1. Which of the following statements is correct?  
A. Ethylene glycol is a colorless, odorless, and sweet-tasting liquid. 
B. Ethylene glycol dissolves in water and alcohol. 
C. Ethylene glycol can hold large amount of heat before boiling. 
D. all of the above. 
To review relevant content, see “Definition” and “Properties” in this 
section. 
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Where Is Ethylene Glycol Found? 
Learning 
Objective 
Upon completion of this section, you should be able to 
• identify sources of ethylene glycol exposure. 
Introduction The most common source of ethylene glycol exposure is antifreeze, 
which can contain up to 95% ethylene glycol. Antifreeze is readily 
available at hardware and automotive stores. 
Waste streams produced from the manufacture or use of ethylene glycol 




Commercial products* containing high concentrations of ethylene glycol 
include 





* Use of trade names is for identification only and does not imply 
endorsement by the Public Health Service or the U.S. Department of 




Waste streams produced when ethylene glycol is manufactured or used 
account for the most significant releases of this compound into 
environment. In military and commercial aviation, large amounts of 
ethylene glycol are used for de-icing. It is sprayed as an aerosol or mist 
onto airplane wings to prevent ice buildup. Used in this manner, ethylene 
glycol may contaminate groundwater near airports through runoff and 
may expose workers to air levels ranging from  (mg/m3) to 10.4 mg/m3 ( 
i.e., <0.02 parts per million [ppm] to 4.2 ppm) 
Occupational 
Exposure 
People who work in industries that use ethylene glycol may be exposed 
by touching these products or inhaling mists from spraying them. 
According to the guidelines set by the American Conference of 
Governmental Industrial Hygienists (ACGIH), the ceiling limit of ethylene 
glycol in workplace air is 39.4 ppm. (American Conference of 
Governmental Industrial Hygienists. 2003) Except for operations where 
ethylene glycol has been sprayed or made into a mist or vapor, exposure 
to it in the air is unlikely (Agency for Toxic Substances and Disease 
Registry 1997). 
Ethylene glycol is used in spacecraft coolant loops and in aviator 
protective clothing. Both applications present potential for exposure if 
leaks occur.  
Key Points • Antifreeze, which typically consists of 95% ethylene glycol, 
accounts for about 40% of the ethylene glycol produced and is 
easily accessible to the general public. 
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Progress 
Check 
2. The most common source of ethylene glycol exposure is 
A. polyester fibers 
B. antifreeze 
C. cosmetics 
D. resin products 
To review relevant content, see the “Introduction” in this section. 
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How Are People Exposed to Ethylene Glycol? 
Learning 
Objective 
Upon completion of this section, you should be able to 
• identify the primary route of exposure to ethylene glycol. 
Introduction The primary route of ethylene glycol entry into the body is through 
accidental or intentional ingestion.  
Workers in industries producing or using products containing ethylene 




Skin contact is the most likely route of occupational exposure, but 
dermal exposure is not likely to lead to toxic effects. Skin contact while 
handling automotive antifreezes, coolants, and brake fluids is not likely 




Ethylene glycol vapor and mist can be inhaled, particularly when the 
chemical is heated, agitated, or sprayed. A 1981-1983 National Institute 
for Occupational Safety and Health (NIOSH) survey found that an 
estimated 1,133,792 workers were potentially exposed to ethylene glycol 
(NIOSH 1990). 
In one study, prison volunteers were exposed to aerosolized ethylene 
glycol concentrations of 3-67 mg/m3 (1.4-27 ppm) for 20-22 hours a day 
for 1 month. The resulting body fluid levels were 1.6-8.4 mg% for urine 
and 8-21.2 mg% for serum. The participants showed no serious signs of 
ethylene glycol intoxication, but they did experience nose and throat 
irritation (Wills, Coulston et al. 1974). No reports of adverse health 
effects from chronic ethylene glycol environmental exposures were 
found.  
Ingestion In the general population, ethylene glycol exposure occurs most 
commonly through ingestion of antifreeze. In the United States, the 
Toxic Exposure Surveillance System (TESS) prepared by the American 
Association of Poison Control Centers documented 4,829 cases of 
ethylene glycol poisonings, 31% experienced toxicity and needed 
treatment, and 9 cases were fatal in 1996 (Litovitz TL 1997), 2,174 cases 
treated in health care facilities in 1998 (Litovitz TL 1999), 6,281 ethylene 
exposures and 23 deaths in 1999 (Litovitz TL 2000), 5562 exposures; 
2109 treated; 23 deaths in 2004 (Watson WA 2004). 
Who Is at Risk 
of Exposure? 
Workers at greatest risk of exposure are in industries that manufacture 
or use products containing ethylene glycol, particularly operations 
involving  
• automobile maintenance 
• aircraft de-icing 
Exposure at 
Home 
In the general population, ethylene glycol exposure occurs most 
commonly through ingestion of antifreeze. Ethylene glycol exposure in 
the general population may also result from skin contact while handling 
• automotive antifreezes 
• coolants 
• brake fluids 
Such exposures, however, are not likely to cause adverse health effects 
under normal conditions. 
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Key Points • Workers in industries producing or using products containing 
ethylene glycol are at greatest risk of exposure. 
• General population exposures occur most commonly through 
accidental or intentional ingestion. 
Progress 
Check 
3. High doses that could produce harmful effects usually result from 
which of the following route of exposure to ethylene glycol 
A. inhalation 
B. ingestion 
C. dermal contact 
D. All are equally important 
To review relevant content, see “Ingestion” in this section. 
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What Are the U.S. Standards for Ethylene Glycol Exposure Levels? 
Learning 
Objectives 
After completing this section, you will be able to 
• identify the ACGIH ceiling exposure limit for ethylene glycol, and 
• identify the EPA guidelines for ethylene glycol in drinking water. 
Introduction The government has developed regulations and guidelines for ethylene 





The Occupational Safety and Health Administration (OSHA) has not set a 
permissible exposure limit (PEL) for ethylene glycol 2 , OSHA did enact a 
ceiling limit of 125 mg/m3 (50 ppm) in 1989, but that level, along with 
375 others, was vacated for procedural reasons by the 11th Circuit 
Federal Court in 1993. ACGIH (American Conference of Governmental 
Industrial Hygienists. 2003) recommends a ceiling exposure limit of 100 





EPA recommends that children be exposed to no more than 20 mg/L (20 
ppm) ethylene glycol in drinking water for 1 day, or 6 mg/L (6 ppm) per 
day over 10 days. They also recommend that adults be exposed to no 
more than a daily total of 7 mg/L (7 ppm) for a lifetime (FSTRAC 1990).  
Food 
The Food and Drug Administration (FDA) has approved ethylene glycol as 
an indirect food additive, for use only as a component of adhesives used 
in packaging. 
Key Points • ACGIH recommends a ceiling exposure limit of 100 mg/m3 (39.4 
ppm). 
• EPA recommends that children be exposed to no more than 20 mg/L 
(20 ppm) ethylene glycol in drinking water for 1 day, or 6 mg/L (6 
ppm) per day over 10 days. They also recommend that adults be 
exposed to no more than a daily total of 7 mg/L (7 ppm) for a 
lifetime. 
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4. ACGIH recommends a ceiling exposure limit for ethylene glycol of  
A. 50 mg/m3 
B. 100 mg/m3 
C. 200 mg/m3 
D. none of the above. 
To review relevant content, see “Key Points” in this section. 
5. EPA recommends that, for a life-time ethylene glycol exposure of an 
adult, the limit should be no more than a daily total of 
A. 20 mg/L (20 ppm) 
B. 6 mg/L (6 ppm) 
C. 7 mg/L (7 ppm) 
D. none of the above 
To review relevant content, see “Environment” in this section. 
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What Is the Biological Fate of Ethylene Glycol? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• describe why individuals with impaired liver function are more 
likely to suffer less toxicity, but greater intensity of the initial CNS 
effects caused by ethylene glycol exposure. 
Introduction Ethylene glycol is rapidly absorbed from the gastrointestinal tract and 
slowly absorbed through the skin or lungs. The toxicity of ethylene 
glycol results from its metabolism to more toxic metabolites. Like 
ethanol, ethylene glycol is rapidly absorbed in the GI tract, with peak 
absorption in 30-60 minutes.  
Rapid 
Transformation  
Because it is highly water-soluble, ethylene glycol is distributed 
throughout total body water. Peak tissue levels occur several hours after 
ingestion. Approximately 24 to 48 hours later, it is difficult to detect 
ethylene glycol in urine or tissues, thus indicating rapid 
biotransformation.  
The normal serum half-life of ethylene glycol has been estimated to be 
about 2.5 hours in children and 3-8 hours in untreated adults. 
Metabolism in 
the Liver 
Other than its inebriating effects, ethylene glycol has relatively low 
toxicity. However, ethylene glycol is metabolized in the liver by 
successive oxidations to a variety of compounds that include 
• glycoaldehyde  
• glycolic acid 
• glyoxylic acid 
• oxalic acid 
These compounds are more toxic than ethylene glycol itself (Figure 1) 
(Jacobsen and McMartin 1986; Hall AH 1992; Goldfrank LR 1998). 
Some of these compounds have elimination half-lives of up to 12 hours. 
The Role of 
Alcohol 
Dehydrogenase  
The rate-limiting step in this metabolic process is the conversion of 
ethylene glycol to glycoaldehyde, a process that is catalyzed by alcohol 
dehydrogenase (ADH).  
Several factors may influence susceptibility to ethylene glycol-induced 
toxicity, including 
• individual differences in levels of liver ADH activity, and 
• nutritional deficiencies, notably lack of thiamine or pyridoxine (two 
vitamins that mediate the metabolic detoxification of ethylene 
glycol). 
Concomitant or recent ethanol exposure can decrease or prevent 
toxicity by preferentially competing for ADH, thereby inhibiting 
transformation of ethylene glycol to glycoaldehyde. Coadministration of 
ethanol increases the percentage of ethylene glycol excreted unchanged 
in the urine. Under normal conditions only a small fraction of ethylene 
glycol (less than 20% after low-dose ingestion) is excreted unchanged. 
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Fomepizole A new medication, fomepizole or 4-methylpyrazole, targets the ADH 
enzyme as well (Baud, Galliot et al. 1988; Brent, McMartin et al. 1999; 
Jones and Volans 1999). Both ethanol and fomepizole are used 
therapeutically to treat ethylene glycol intoxication. Ethanol increases 
the half-life of ethylene glycol in the body to 17-18 hours; fomepizole 
increases the half-life to 11-14.75 hours. 
 Figure 1. Metabolism of ethylene glycol. Adapted from  Hall 1992. 
Key Points • Ethylene glycol is rapidly absorbed by the gastrointestinal tract. 
Dermal absorption is slow. Inhalation is generally not associated with 
toxicity.  
• Ethylene glycol is metabolized in the liver to a variety of compounds 
of increasing toxicity, such as glycoaldehyde, glycolic acid, and 
glyoxylic acid. 
• Under normal conditions, only a small fraction of absorbed ethylene 
glycol is unchanged when excreted in the urine.  
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6. Persons with reduced ability to metabolize ethylene glycol are 
A. more likely to suffer the severe toxicity, less likely to experience 
greater intensity of the initial CNS effects 
B. less likely to suffer the severe toxicity, more likely to experience 
greater intensity of the initial CNS effects 
C. more likely to suffer the severe toxicity and experience greater 
intensity of the initial CNS effects 
D. less likely to suffer the severe toxicity or experience greater 
intensity of the initial CNS effects. 
To review relevant content, see “Metabolism in the Liver” in this 
section. 
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What Are the Stages of Ethylene Glycol Intoxication? 
Learning 
Objectives 
Upon completion of this section, you should be able to 
• explain the mechanism of ethylene glycol toxicity and 
• describe the three stages of ethylene glycol toxicity. 
Introduction  Ethylene glycol itself is toxic, but its harmful effects mainly result from 
the accumulation of its more toxic metabolites. 
Ethylene glycol is a central nervous system (CNS) depressant that can 
produce acute effects similar to those of ethanol. These CNS effects 
predominate during the first hours after exposure. 
Mechanism of 
Toxicity 
The main toxicity results from hepatic metabolism of ethylene glycol to 
glycoaldehyde, glycolate, glyoxylate, and oxalate. These metabolites 
inhibit 
• oxidative phosphorylation and cellular respiration 
• glucose and serotonin metabolism 
• protein synthesis 
• DNA replication 
• ribosomal RNA formation 
The accumulation of organic acid metabolites, especially glycolic acid, 






Severe ethylene glycol poisoning may go through three stages: CNS 
depression, cardiopulmonary toxicity, and renal toxicity (Table 1)  
(Friedman, Greenberg et al. 1962). However, signs and symptoms in an 
individual patient might not be separated so cleanly and could have 
much overlap. 
Stage 1 (CNS depression phase) 
CNS depression begins soon after exposure, lasting for up to 12 hours 
after ingestion. This depression appears similar to ethanol intoxication, 
but without the characteristic odor of alcohol. Initially, the inebriation, 
euphoria, slurred speech, sleepiness, and so forth are due to the 
unmetabolized ethylene glycol.  
After the glycoaldehyde forms (at 4-12 hours) and metabolic acidosis 
begins, CNS depression—if it is a serious intoxication—can lead to the 
following effects: 
• seizures  
• coma  
• cerebral edema (in some cases) 
• gastrointestinal irritation (nausea and vomiting) 
An osmolal gap, without metabolic acidosis, or an anion gap may be seen 
before significant metabolism of ethylene glycol occurs. As ethylene 
glycol is metabolized, the osmolal gap, if present, will decrease and an 
anion gap metabolic acidosis evolves. Patients who present late may 
have renal failure with normal osmolal and anion gaps and no acidosis or 
measurable ethylene glycol levels (Ford M 1991). 
Signs of metabolic acidosis due to the metabolites may become apparent 
late in stage 1. 
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Stage 2 (Cardiopulmonary toxicity phase) 
The following cardiorespiratory symptoms may appear 12-24 hours after 
ingestion 
• tachycardia, 
• tachypnea, and 
• hypertension or hypotension. 
The following conditions may develop in this stage 
• pulmonary edema, 
• pneumonitis, 
• congestive cardiac failure, and 
• shock. 
Formation of oxalic acid may lead to deposition of calcium oxalate 
crystals in  
• the meninges, 
• blood vessel walls, 
• lung, and 
• myocardium. 
These deposits can cause tissue injury. They also may lead to 
hypocalcemia secondary to calcium oxalate precipitation. Most deaths 
from ethylene glycol poisoning occur during stage 2. 
Stage 3 (Renal toxicity phase) 
Kidney damage usually develops 24-72 hours after exposure. Acidosis 
and acute renal failure may result from deposition of calcium oxalate 
crystals in the kidneys.  
The following conditions characterize the third phase 
• flank pain, 
• costovertebral angle tenderness, and 
• oliguric renal failure. 
Prolonged, rarely permanent, kidney failure is distinguished by 
• proteinuria, 
• hematuria, 
• crystalluria, and 
• increased serum BUN and creatinine. 
Calcium oxalate crystals may appear in the urine as early as stage 1, but 
absence of these crystals does not rule out the diagnosis of ethylene 
glycol poisoning. 
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Signs and symptoms 




Inebriation, euphoria, ataxia, slurred speech, 
drowsiness, irritation, restlessness, and 
disorientation 
  Gastrointestinal Nausea and vomiting 
  Metabolic Elevated osmolal gap 
2 12 to 24 
hours 
Cardiovascular Mild hypertension, tachycardia, and shock 
  Pulmonary Tachypnea, adult respiratory distress 
syndrome, pulmonary edema, and 
pneumonitis 
  Metabolic Metabolic acidosis with elevated anion gap 
and decreased osmolal gap, possible tetany 
from hypocalcemia, and hyperventilation 
3 24 to 72 
hours 
Renal Flank pain, costovertebral angle tenderness, 
oliguric renal failure, hyperkalemia, and 
hypocalcemia 
  Metabolic May have normal anion and osmolal gaps. 
 
• Unmetabolized ethylene glycol contributes to CNS depression. Key Points 
Progress 
Check 
7. Which of the following cellular biochemical reactions can be inhibited 
by acid and aldehyde metabolites of ethylene glycol? 
A. oxidative phosphorylation and cellular respiration 
B. protein synthesis 
C. DNA replication 
D. all of the above 
To review relevant content, see “Mechanism of Toxicity” in this 
section. 
8. Tachypnea generally appears in which of the following stages: 
A. Stage 1 (0.5 – 12 hr) 
B. Stage 2 (12 – 24 hr) 
C. Stage 3 (24 – 72 hr) 
D. Stage 2 and 3 ( 12 – 72 hr) 
To review relevant content, see “Table 1” in this section. 
 
• Delayed clinical toxicity results from conversion of ethylene glycol to 
metabolites of greater toxicity. 
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What Are the Physiological Effects of Ethylene Glycol Poisoning? 
Learning 
Objectives 
Upon completion of this section, you should be able to  
• describe the physiologic effects of ethylene glycol poisoning. 
Introduction Ingestion of ethylene glycol has significant toxicological implications if 
undetected or left untreated. The preceding section described the clinical 
features of ethylene glycol poisoning in three stages that are based on 
the time after ingestion. This section depicts the systemic effects 
associated with significant ethylene glycol exposure.  
Neurologic 
Effects 
The initial phase of ethylene glycol poisoning is characterized by 
inebriation caused by unmetabolized ethylene glycol. In acute poisoning 
cases, the following symptoms are common (Parry and Wallach 1974; 
Buell, Sterling et al. 1998)  
• ataxia 







Possible sequelae of severe poisonings  (Walder and Tyler 1994; 
Hantson, Vanbinst et al. 2002) include  
• myoclonic jerks 
• convulsions 
• coma 
• death  
Cerebral edema and deposition of calcium oxalate crystals in the walls of 
small blood vessels in the brain contribute to this CNS toxicity (Jobard, 
Harry et al. 1996; Bey, Walter et al. 2002; Tobe, Braam et al. 2002). 
Some studies also documented brain dysfunction with corresponding 
cranial computed tomography findings after ethylene glycol ingestion 




Recovery in survivors is usually rapid and complete. However, the 
following cranial nerve palsies have been reported one or more weeks 
after acute exposure  
• facial palsy 
• hearing loss 
• dysphagia 
• opthalmoplegia 
• visual disturbances  
Such adverse effects are not seen often, but delayed treatment may 
contribute to their development. Such adverse effects are not seen often, 
but delayed treatment may contribute to their development (Momont and 
Dahlberg 1989; Broadley, Ferguson et al. 1997; Lewis, Smith et al. 
1997; Tobe, Braam et al. 2002). 
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Respiratory 
Effects 
Inhaled ethylene glycol can irritate the respiratory tract.  
• Throat and upper respiratory irritation were the most common 
complaints following prolonged experimental exposures in humans (4 
weeks at concentrations of 1-25 ppm).  
• Exposure to 60 ppm aerosolized ethylene glycol caused very 
noticeable irritation. 
• Exposure to 80 ppm aerosolized ethylene glycol was judged 
“intolerable” because respiratory discomfort developed rapidly (Wills, 
Coulston et al. 1974).  
Pulmonary effects typically occur 12 to 72 hours after ingestion of 
ethylene glycol. Pulmonary edema and adult respiratory distress 
syndrome (ARDS) have been reported in ethylene glycol victims (Haupt, 
Zull et al. 1988; Piagnerelli, Carlier et al. 1999).  
The following respiratory effects often occur 12 hours or more after 
exposure in victims of severe ethylene glycol poisoning.  
• tachypnea, 
• hyperventilation, 
• Kussmaul respirations.  
Such effects most often reflect physiological compensation for severe 
metabolic acidosis rather than primary lung disease (Friedman, 
Greenberg et al. 1962; Parry and Wallach 1974; Godolphin, Meagher et 
al. 1980). Autopsies of ethylene glycol victims revealed the following  
• pulmonary edema with diffuse hemorrhagic exudates, 
• bronchopneumonia (probably caused by aspiration), and 




The following severe cardiovascular effects have been reported in 
ingestion victims, during stage 2 (Friedman, Greenberg et al. 1962; 
Parry and Wallach 1974; Vale 1979):  
• Congestive heart failure with cardiogenic pulmonary edema 
• Circulatory collapse  
Severe metabolic and fluid electrolyte abnormalities (Friedman, 
Greenberg et al. 1962; Parry and Wallach 1974) may cause  
• cardiac dysrhythmias 
• cardiac arrest  
Ingestion of antifreeze (Walder and Tyler 1994),  (Jobard, Harry et al. 
1996; Rasic, Cengic et al. 1999) may affect blood pressure, causing 
either  
• hypertension or 
• hypotension, which may progress to cardiogenic shock. 
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Metabolic 
Effects 
Severe ethylene glycol poisoning is characterized by metabolic acidosis. 
• Onset occurs within 24 hours after ingestion. 
• Acidosis is caused primarily by the accumulation of glycolic and 
glyoxylic acid. Oxalic and excess lactic acid also contribute.  
The metabolic acidosis of ethylene glycol poisoning is characterized as 
normochloremic (Berman, Schreiner et al. 1957; Curtin, Kraner et al. 
1992; Hantson, Hassoun et al. 1998; Bey, Walter et al. 2002)with  
• low serum bicarbonate level and pH 
• elevated acidemia and anion gap  
Ethylene glycol is a small, osmotically active molecule that  
• markedly increases plasma osmolality 
• causes a large osmolal gap  
Osmolality reflects the number of solute particles in a solution. Numerical 
measures of osmolality express the number of particles present in a 
given weight of solvent.  
Tetany can sometimes occur due to hypocalcemia that results from 
precipitation of calcium by the oxalate formed during ethylene glycol 
metabolism (Parry and Wallach 1974). 
Renal Effects Kidney damage typically occurs during stage 3 of ethylene glycol 
intoxication.  
• Kidney damage manifests as acute oliguric renal failure. 
• Costovertebral angle tenderness is the most common physical finding 
(Friedman, Greenberg et al. 1962). 
• The most characteristic abnormality is the presence of large numbers 
of “tent-shaped” (octahedral) or needle-shaped oxalate crystals in the 
urine (Olivero 1993; Huhn and Rosenberg 1995). 
• Absence of oxalate crystals does not rule out the diagnosis of 
ethylene glycol poisoning (Haupt, Zull et al. 1988; Curtin, Kraner et 
al. 1992; Baum, Langman et al. 2000; Boyer, Mejia et al. 2001; 
Hantson, Vanbinst et al. 2002).  
Other typical urinalysis abnormalities are  




• elevated serum BUN and creatinine  
Disturbed renal function may be mild and short-lived or severe and 
persistent for several months. Permanent renal insufficiency is 
uncommon but does occur (Berman, Schreiner et al. 1957; Friedman, 
Greenberg et al. 1962; Parry and Wallach 1974; Buell, Sterling et al. 
1998; Hantson, Hassoun et al. 1998).  
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The toxicity of ethylene glycol is linked with two metabolites.  
• Glycolic acid, which causes the acidosis. 
• Oxalic acid. 
o Oxalic acid is poorly soluble in the presence of calcium. 
o Calcium oxalate crystals in the urine are diagnostic.  
o The precipitation of oxalate crystals in the tubular lumen leads 
to luminal blockage and compression-induced loss of 
glomerular filtration (renal failure). 
In transformed kidney cells, the oxalate ion induces cytotoxic damage 
(McMartin and Cenac 2000). Another study, however, stated that 
glycoaldehyde and glyoxylate are the principal metabolites responsible 




Data are insufficient to determine whether ethylene glycol causes 
cancer or developmental defects.  
• Human studies have shown no link between ethylene glycol 
exposure and cancer or reproductive or developmental hazards. 
• Animal studies have not found an association between ethylene 
glycol exposure and cancer.  
• Ethylene glycol exposure was teratogenic to mice and rats, resulting 
in craniofacial and neural tube closure defects and skeletal dysplasia 
(Lamb, Maronpot et al. 1985; Price, Kimmel et al. 1985; Marr, Price 
et al. 1992; Tyl, Ballantyne et al. 1995). Ethylene glycol itself is 
used to cryopreserve embryos of many mammals and is thus an 
unlikely cause of these abnormalities.  
Other Effects Nausea, vomiting (with or without blood), and abdominal pain are 
frequent early findings following ethylene glycol ingestion (Meditext 
2004). Ethylene glycol is only a minor skin and mucous membrane 
irritant, although a few cases of allergic contact dermatitis have been 
documented (Clayton GD & Clayton FE 1994). Reported effects on the 
blood have included leukocytosis, occasional methemoglobinemia, and 
bone marrow arrest (Verrilli, Deyling et al. 1987; Hantson, Hassoun et al. 
1998; Rasic, Cengic et al. 1999). Reported musculoskeletal effects have 
included muscle tenderness and elevation of creatine kinase (Friedman, 
Greenberg et al. 1962; Parry and Wallach 1974; Verrilli, Deyling et al. 
1987). 
Key Points • Signs of inebriation are among the first symptoms to appear after 
ethylene glycol ingestion.  
• Delays in initiating treatment can result in more severe adverse 
effects. 
• The most common cause of tachypnea is uncompensated metabolic 
acidosis.  
• Ethylene glycol poisoning through ingestion can cause noncardiogenic 
pulmonary edema and ARDS. 
• Ethylene glycol poisoning can cause dysrhythmias and heart failure. 
• Ethylene glycol exposure is characterized by an osmolal gap and a 
metabolic acidosis with an elevated anion gap. 
• Nephrotoxicity is the dominant effect of significant ethylene glycol 
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poisoning. 
• Human studies have shown no link between ethylene glycol exposure 
and cancer or reproductive or developmental hazards. 
Progress 
Check 
9. Signs of inebriation are among the first symptoms to appear after 
ethylene glycol ingestion. Inebriation is caused by  
A. ethanol 
B. unmetabolized ethylene glycol 
C. metabolites of ethylene glycol 
D. none of the above. 
To review relevant content, see “Neurologic Effects” in this section. 
10. The respiratory effects such as tachypnea and hyperventilation often 
occur 12 hours or more after exposure in victims of severe ethylene 
glycol poisoning. Such effects most often reflect  
A. physiological compensation for severe metabolic acidosis 
B. primary lung disease 
C. adult respiratory distress syndrome (ARDS) 
D. all of the above 
To review relevant content, see “Respiratory Effects” in this section. 
11. The metabolic acidosis of ethylene glycol poisoning is characterized 
as  
A. normochloremic 
B. low bicarbonate level and pH 
C. elevated acidemia and anion gap  
D. all of the above 
To review relevant content, see “Metabolic Effects” in this section. 
12. Which of the following statements about nephrotoxicity resulting from 
significant ethylene glycol poisoning is correct?  
A. Kidney damage manifests as acute oliguric renal failure. 
B. Urine contains many oxalate crystals. 
C. Absence of oxalate crystals in the urine does not rule out a 
diagnosis of ethylene glycol poisoning. 
D. all of the above. 
To review relevant content, see “Renal Effects” in this section. 
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How Should Patients Exposed to Ethylene Glycol Be Evaluated? 
Learning 
Objective 
Upon completion of this section, you should be able to describe  
• the primary focuses of the exposure history and 
• how the actual clinical presentation changes over time as intoxication 
evolves. 
Introduction Ethylene glycol ingestion is a medical emergency requiring prompt 
recognition and aggressive treatment.  
• The actual clinical presentation changes over time as intoxication 
evolves. 
• Signs and symptoms depend on the amount ingested and concurrent 
use of alcohol.  
Therefore, making a correct diagnosis requires a reliable history of the 
time, route, and magnitude of exposure. In some cases, however, a 
detailed history can be difficult to obtain because of the patient’s altered 
mental state. If ethylene glycol poisoning is strongly suspected, begin 
appropriate treatment while waiting for confirmation by laboratory results 
(Stokes and Aueron 1980; Johnson, Meggs et al. 1999).  
Patients who have been exposed to ethylene glycol should undergo a 
thorough medical evaluation. Early and accurate diagnosis is important in 
deciding appropriate care strategies. In cases of ethylene glycol 
exposure, medical evaluation should include  
• an exposure history, 
• a physical examination, 
• an assessment of clinical presentation, and 
• laboratory tests  
This section focuses on the first three items, which are typically 
conducted during the patient’s visit to your office. Recommended tests 




Although environmental exposures to ethylene glycol are a concern, 
nearly all cases of ethylene glycol poisoning are due to ingestions 
(Agency for Toxic Substances and Disease Registry 1997).  
• A careful history of possible substance abuse and a meticulous search 
in the home for ethylene glycol-containing compounds should be 
made in all suspected poisonings. 
• A history of ethanol abuse may suggest ingestion of ethylene glycol 
as an ethanol substitute. Teens may experiment with this compound. 
• Regional poison control centers can often assist in identifying the 
contents of bottles and packages if product labels do not list the 
chemical ingredients.  
• Inquiring about similar symptoms in family members, friends, and 
coworkers may be helpful in identifying a common source of 
exposure.  
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The patient’s vital signs should be monitored. Although not specific for 
ethylene glycol intoxication, the following symptoms have been 
associated with moderate or severe poisoning (Friedman, Greenberg et 
al. 1962; Parry and Wallach 1974):  
• tachypnea, 
• tachycardia, 
• mild hypertension, and 
• low-grade fever  
A complete neurologic examination should be performed. Pay special 
attention to  
• mental status, 




Patients who have ingested ethylene glycol often progress through three 
clinical stages (Friedman, Greenberg et al. 1962) (described earlier, 
Stages of ethylene glycol intoxication) that represent a continuum. 
Individual patients may develop any combination of organ or systemic 
effects (Table 1). The time course for each stage, as well as the severity 
of illness, depends on the amount of ethylene glycol ingested and 
whether ethanol was ingested concurrently. 
Stage 1  
During the first 12 hours after ingestion, the following CNS effects 
predominate  
• headache, 
• slurred speech, 
• confusion, 
• tremor, and 
• nystagmus. 
Stage 2 
Stage 2 begins 12-24 hours after ingestion and is caused by the products 
of ethylene glycol metabolism. The primary manifestations are 
cardiopulmonary  
• tachypnea, 
• tachycardia, and 
• hypertension. 
You may also see  
• hypotension, 
• dysrhythmias, 
• respiratory distress syndrome, 
• pulmonary edema, and 
• profound metabolic acidosis. 
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Stage 3 
Stage 3 occurs 24-72 hours after ingestion, if the condition is not 
treated. Acute renal dysfunction may occur, ranging from mild elevations 
in BUN and serum creatinine to oliguric renal failure.  
• Renal dysfunction usually resolves, but may be irreversible.  
• Myopathy and bone marrow suppression have also been reported.  
In some cases, cranial nerve abnormalities may develop several days 
after exposure. These neurologic sequelae are usually found when 
treatment is delayed or inadequate. 
Key Points • A detailed history is important in diagnosing ethylene glycol 
poisoning.  
• Prompt recognition and early therapeutic intervention are essential 
to preventing latent effects and potential sequelae of ethylene glycol 
poisoning. 
• Patients poisoned with ethylene glycol may initially appear inebriated 
and may lack other signs and symptoms of severe toxic exposure.  
• After a characteristic latent period, metabolites of ethylene glycol can 
cause potentially life-threatening illness. 
Progress 
Check 
13. Why is a detailed history important in diagnosing ethylene glycol 
poisoning?  
A. Making a correct diagnosis requires a reliable history of the time, 
route, and magnitude of exposure. 
B. A history of ethanol abuse may suggest ingestion of ethylene 
glycol as an ethanol substitute. 
C. A careful history about similar symptoms in family members, 
friends, and coworkers may be helpful in identifying a common 
source of exposure. 
D. all of the above. 
To review relevant content, see “Exposure History” in this section. 
14. Prompt recognition and early therapeutic intervention are essential in 
clinical management of ethylene glycol poisoning. Why?  
A. After a characteristic latent period, metabolites of ethylene glycol 
can cause potentially life-threatening illness. 
B. Prompt recognition and aggressive treatment may prevent latent 
effects and potential sequelae of ethylene glycol poisoning. 
C. Time is of the essence in the case of serious ethylene glycol 
poisoning because the renal failure may occur just a matter of 
days if no appropriate treatment is instituted.  
D. all of the above. 
To review relevant content, see “Clinical Presentation” in this section. 
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Upon completion of this section, you should be able to  
• identify the abnormal laboratory findings associated with ethylene 
glycol poisoning and 
• list three measurements that can assist with diagnosis of ethylene 
glycol poisoning. 
Introduction  All patients with known or suspected ethylene glycol ingestion require the 
following tests  
• arterial blood gases 
• blood glucose 
• serum electrolytes 
• blood ethanol  
Other helpful laboratory tests may include  
• serum BUN and creatinine 
• calcium and magnesium levels 
• acetaminophen and aspirin levels 
• liver function tests 
• urinalysis (with special attention to crystalluria)  
A measured osmolality by the freezing point depression method is 
needed to detect an osmolal gap. Results of these laboratory tests will 
confirm the presence and degree of metabolic acidosis and allow 





A blood ethanol level will establish whether initial CNS symptoms may be 
due to ethanol. The presence of ethanol will also have a substantial 
impact on metabolism and therapy. Patients who have both anion and 
osmolal gap should also have blood methanol tests. Serum lactate and β-
hydroxybutyrate levels may be indicated for an alcoholic patient, if 
alcoholic ketoacidosis is suspected (Meditext 2004). 
Urinary 
Crystals 
The presence of calcium oxalate or hippurate crystals in the urine, 
together with an elevated anion gap or osmolal gap, strongly suggests 
ethylene glycol poisoning (Albertson 1999). Urinary crystals result from  
• the precipitation of calcium by the oxalic acid metabolite of ethylene 
glycol 
• the reaction of the glycine metabolite with benzoic acid, which forms 
hippuric acid  
Urinary crystals can take many forms 
• dumbbells 
• envelopes 
• needles (most commonly)  (Jacobsen, Hewlett et al. 1988)  
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Absence of urinary crystals, however, does not rule out poisoning. 
Numerous studies have documented that renal damage occurs after 
ethylene glycol ingestion without deposition of calcium oxalate crystals in 
the kidney (Vale 1979; Hall AH 1992). 
Urine 
Fluorescence 
Because some antifreeze products contain fluorescein, the urine may 
fluoresce under a Wood’s lamp (Winter, Ellis et al. 1990). However, 
recent studies argued if Wood’s lamp determination of urine fluorescence 
could be a reliable diagnostic test (Casavant, Shah et al. 2001; Wallace, 
Suchard et al. 2001; Sharma, O'Shaughnessy et al. 2002). 
Serum 
Analysis 
An elevated serum level of ethylene glycol confirms ethylene glycol 
poisoning. Significant toxicity is often associated with levels greater than 
25 milligrams per deciliter (mg/dL) (Hall AH 1992; Goldfrank LR 1998). 
False Positives Communication with the laboratory is critical in poisoning cases for 
several reasons.  
• 2,3-butanediol, often found in the plasma of alcoholics, can be 
mistakenly identified as ethylene glycol when the analysis is 
performed by gas chromatography (Jones, Nilsson et al. 1991). 
• Propylene glycol can also interfere with some ethylene glycol assays 
(Robinson, Scott et al. 1983; Apple, Googins et al. 1993; Hilliard, 
Robinson et al. 2004).  
• An inherited metabolic disorder can present as ethylene glycol 
intoxication from laboratory results (Pien, van Vlem et al. 2002). 
Glycolic Acid 
Analysis 
Recent studies have demonstrated usefulness of glycolic acid analysis in 
ethylene glycol poisoning cases (Fraser 1998; Porter, Rutter et al. 2001; 
Fraser 2002). Most laboratories routinely screen for unchanged ethylene 
glycol in suspected poisonings. They estimate the amount of ethylene 
glycol present in positive cases even though toxicity from ethylene glycol 
exposure is primarily caused by one metabolite—glycolic acid. Measuring 
glycolic acid in ethylene glycol poisonings has certain advantages  
 
• findings correlate better with ethylene glycol toxicity than ethylene 
glycol levels 
• findings determine how much ethylene glycol has metabolized to 
glycolic acid 
• the presence of glycolic acid objectively indicates toxicity 
• the test confirms that the metabolic acidosis was due to ethylene 
glycol poisoning rather than another cause (Fraser 2002)  
Yao and Porter (1996) were the first to develop a procedure for 
simultaneously determining ethylene glycol and its major toxic 
metabolite, glycolic acid. Porter and colleagues published a modification 




The presence of metabolic acidosis with both anion and osmolal gaps is 
an important clue to the diagnosis  (Friedman, Greenberg et al. 1962; 
Parry and Wallach 1974; Szerlip 1999). Numerous toxic substances are 
associated with an elevated anion gap (Table 2)  (Goldfrank LR 1990). 
An elevated osmolal gap suggests the presence of a low-molecular 
weight substance.  
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Only four significant conditions will cause metabolic acidosis and elevate 
both the anion and osmolal gaps  
1. methanol poisoning 
2. ethylene glycol poisoning 
3. alcoholic ketoacidosis 
4. diabetic ketoacidosis  
Acetone causes an osmolal gap. Lactic acidosis or propylene glycol 
intoxication also is capable of causing metabolic acidosis with osmolal 
gap.  
However, when large quantities of ethanol and ethylene glycol are 
ingested concurrently, metabolic acidosis may be inhibited or delayed. In 
such cases, the patient may initially develop an osmolal gap but will not 
immediately develop acidosis or an anion gap.  
Although an osmolal gap is often cited as indirect evidence of the 
presence of an exogenous alcohol or glycol, other substances or 
conditions may be causative. Conversely, failure to find an osmolal gap 
may lead to the erroneous assumption that no exogenous substances are 
present. A small osmolal gap may, however, represent a significant 
alcohol level.  
Caution must be used when interpreting the osmolal gap. Recent reviews 
argued that the use of the osmolal gap as a screening tool for ethylene 
glycol has significant limitations and remains hypothetical (Glaser 1996; 
a, Purssell et al. 2004; Purssell, Lynd et al. 2004). 
 










Methanol + ++ – + 
Blindness and pink 
edematous optic disk 
Ethanol + + + + Alcoholic ketoacidosis 
Ethylene 
glycol  
+ ++ – + 
Renal failure, calcium 
oxalate and hippurate 
crystals, CNS depression, 
tachycardia, and 
tachypnea 




Salicylates + + + – 
Vomiting, tinnitus, and 
hyperthermia 
Adapted from Goldfrank LR 1990. 
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An ethylene glycol level (in mg/dL) may be estimated from the osmolal gap 
(OG) if it is the only osmotically active poison present and levels are taken 
early in the course. This is most accurate if the ethylene glycol level is 
between 50 to 100 mg/dL:  
Estimated ethylene glycol level = OG × 6.2. 
 
The serum anion gap (AG) is determined from serum electrolytes measured in 
mEq/L and may be defined by the formula: 
AG = ( Na+ + K+) – ( Cl– + HCO3–) 
 (Normal anion gap: 12 to 16)  
The serum osmolal gap (OG) is most commonly approximated by the formula:  
OG = osmolality (measured)* – 2Na+ + [BUN divided by 2.8]  
+ [glucose divided by 18]  
+ [BAT (ethanol) divided by 4.6 (if present)] 
(Normal osmolal gap: < 10) 
*In this formula, osmolality (measured) is obtained by the freezing-point–
depression method and expressed in milliosmoles per liter (mOsm/L); Na+ in 
mEq/L; BUN and glucose in mg/dL; blood alcohol test (BAT) in mg/dL. 
Figure 2. Formulas for calculating anion and osmolal gaps. (Goldfrank 




• Ethylene glycol poisoning is strongly suggested by  
o an elevated anion-gap metabolic acidosis 
o an elevated osmolal gap  
o urinary crystals  
• Measurement of serum ethylene glycol levels can confirm poisoning. 
Progress 
Check 
15. Which of the following is the most reliable diagnostic index for 
suspected ethylene glycol ingestion?  
A. an elevated anion gap and an increased osmolal gap 
B. normochloremic metabolic acidosis  
C. calcium oxalate or hippurate crystalluria  
D. elevated serum ethylene glycol level 
To review relevant content, see “Introduction” in this section. 
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16. Glycolic acid analysis has all of the following advantages except  
A. Findings correlate better with ethylene glycol toxicity than 
ethylene glycol levels. 
B. Findings determine how much ethylene glycol has metabolized to 
glycol acid. 
C. The test confirms that the metabolic acidosis was due to ethylene 
glycol poisoning rather than another cause. 
D. Glycolic acid analysis is routinely performed in most laboratories. 
To review relevant content, see Glycolic Acid Analysis in this section. 
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How Should Patients Exposed to Ethylene Glycol Be Treated? 
Learning 
Objectives 
Upon completion of this section, you should be able to  
• identify the primary treatment strategy for managing ethylene glycol 
poisoning cases. 
Introduction Treatment should not be delayed pending results of ethylene glycol 
serum levels if the patient’s condition or history suggests such 
poisoning. Treatment advice can be obtained from a regional poison 




Initial management of suspected poisoning  
• includes basic life support 
• may require intubation and mechanical ventilation 
Prevent 
Absorption 
When the ingestion is recent, take steps to prevent ethylene glycol 
absorption.  
• Induced emesis or gastric lavage may be useful if  
o ingestion occurred within 2 hours 
o the patient has a normal level of consciousness 
• Activated charcoal adsorbs ethylene glycol poorly and is probably 
not effective in this setting (Goldfrank LR 1998).  
Specific 
Treatment 
Specific treatment for ethylene glycol poisoning includes  
• sodium bicarbonate to correct the metabolic acidosis as indicated, 
• ethanol or fomepizole (Antizol) to competitively inhibit metabolism 
of ethylene glycol to its more toxic metabolites, and 
• hemodialysis, if indicated, to remove ethylene glycol and glycolic 
acid. (Stokes and Aueron 1980; Gabow, Clay et al. 1986; Cheng, 
Beysolow et al. 1987; Malmlund, Berg et al. 1991; Jacobsen and 
McMartin 1997; Moreau, Kerns et al. 1998; Bey, Walter et al. 2002)  
This treatment strategy is effective in most cases, but renal failure and 
death can occur if treatment is delayed.  
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Table 3. Intravenous administration of ethanol in ethylene glycol and methanol 
poisoning.*
Dose Level† Milliliters (mL) of 10% Ethanol‡
Loading 600 to 800 mg/kg 7.6 to 10/kg 
Maintenance   
Chronic alcoholic 154 mg/kg/hr 1.95 kg/hr 
 Social drinker 110 mg/kg/hr 1.39 kg/hr 
 Nondrinker 66 mg/kg/hr 0.83 kg/hr 
During hemodialysis§   
 Chronic alcoholic 304 mg/kg/hr 3.95 kg/hr 
 Social drinker 256 mg/kg/hr 3.29 kg/hr 
 Nondrinker 216 mg/kg/hr 2.70 kg/hr 
*The goal of ethanol therapy is to maintain the blood ethanol level between 100 and 150 
mg/dL. 
†mg/kg: milligrams per kilogram; mg/kg/hr: milligrams per kilogram per hour. 
‡In 5% dextrose in distilled water (D5W) per kilogram body weight. 
§Assuming no ethanol is added to dialysis bath. 





Prolonged administration of ethanol can cause hypoglycemia, particularly 
in children; therefore, blood glucose should be monitored closely 
throughout treatment. The hypoglycemia that develops in adults is often 
overlooked because the impairment of mental status is attributed to the 
ethanol. 
• Infuse the loading dose and the maintenance dose over the first hour 




• The patient’s actual drinking habits determine the appropriate dose. 
If those drinking habits cannot be determined, it is best to use the 
doses for the category of “social drinker.” 
• Adjust doses to achieve a blood ethanol level between 100 and 150 
mg/dl, although levels as low as 70 mg/dL have almost completely 
inhibited ethylene glycol metabolism in some patients (Jacobsen, 
Ostby et al. 1982).  
To prepare 1 L of 10% ethanol in 5% dextrose in distilled water (D5W) 
for intravenous infusion, perform either of the following steps  
• Remove 100 ml of fluid from 1 L of D5W and replace with 100 ml of 
absolute ethanol, or  
• Remove 50 ml of fluid from 1 L of commercially available 5% ethanol 
in D5W solution and replace with 50 ml of absolute ethanol. 
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Monitor the 
Dose 
Monitor blood ethanol and serum glucose levels at the end of the loading 
dose and hourly until the maintenance dose is adjusted. Both should 
then be monitored 2-3 times daily, along with blood glucose. More 
frequent monitoring is required during dialysis.  
Most ethylene glycol (93.75%) is eliminated over 4 half-lives (prolonged 
to 17 hours with therapy). Therefore, most ethylene glycol should be out 
of the body within 68 hours (2.83 days). Ethanol therapy should be 
continued for 3 days if ethylene glycol levels are not available, or until 
the following conditions are met (Burkhart and Kulig 1990):  
• ethylene glycol level <20 mg/dL 
• resolution of the acidosis (normal ABGs, pH) 





Fomepizole (Antizol) was approved by the FDA in December 1997 for 
use as an ADH antagonist in treatment of ethylene glycol poisoning. The 
following criteria  (Barceloux, Krenzelok et al. 1999) were developed by 
the American Academy of Clinical Toxicology for using fomepizole rather 
than ethanol:  
• ingestion of multiple substances, resulting in depressed level of 
consciousness 
• altered consciousness 
• lack of adequate intensive care staffing or laboratory support to 
monitor ethanol administration 
• relative contraindications to ethanol 
• critically ill patient with an anion-gap metabolic acidosis of unknown 
origin and potential exposure to ethylene glycol 
• patients with active hepatic disease  
The manufacturer recommends a loading dose of 15 mg/kg infused 
intravenously over 30 minutes, followed by doses of 10 mg /kg every 12 
hours for 4 doses, then 15 mg/kg every 12 hours until ethylene glycol 
levels are below 20 mg/dl (Meditext 2004). The dosage must be 




This therapy may obviate the need for hemodialysis in the absence of 
both renal insufficiency and significant metabolic acidosis (Harry, 
Turcant et al. 1994; Harry, Jobard et al. 1998; Borron, Megarbane et al. 
1999; Watson 2000; Brent 2001; Battistella 2002; Druteika, Zed et al. 
2002). In addition, in comparison with ethanol, fomepizole  
• is easier to use clinically and requires less monitoring 
• has a slower rate of elimination 
• has a longer duration of action 
• has a reasonable dosing schedule 
• has less potential for adverse effects 
• is easier to administer 
• results in shorter hospital stays, 
• has more predictable and prolonged results 
• does not cause CNS depression or hypoglycemia 
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The disadvantages of ethanol are that it  
• requires continuous administration and frequent monitoring of serum 
ethanol and glucose levels 
• can cause CNS depression and hypoglycemia 
• poses problems in patient care, such as drunkenness  
Although ethanol costs much less, the savings may be offset by 
additional costs for  
• monitoring the patient 
• lab tests 
• hemodialysis for some patients 
Hemodialysis Hemodialysis should be considered under these conditions (Ford M 
1991; Hall AH 1992):  
• serum ethylene glycol levels exceed 30 mg/dL 
• severe upset in blood pH (pH <7.25) or fluid/electrolyte disturbances 
persist despite decontamination and ethanol or fomepizole therapy 
• vital signs continue to deteriorate despite intensive supportive 
treatment, or 
• renal failure develops  
However, the decision to add hemodialysis in the treatment of ethylene 
glycol poisoning on the basis of plasma ethylene glycol concentrations is 
still debatable  (Battistella 2002). A recent study suggested glycolic acid 
>8 mmol/L as a criterion for the initiation of hemodialysis in ethylene 
glycol ingestion (Porter, Rutter et al. 2001). Hemodialysis should be 
continued until  
• acidosis is controlled 
• serum ethylene glycol level falls below 20 mg/dL  
At that level, ethanol or fomepizole therapy can also be discontinued. In 
contrast, a recent report described successful clinical management of 
pediatric ethylene glycol poisoning cases without hemodialysis  
(Caravati, Heileson et al. 2004). 
Vitamin 
Therapy  
Thiamine and pyridoxine are two water-soluble B-complex vitamins that 
act as metabolic cofactors in the metabolism of ethylene glycol. They  
• promote the transformation of glyoxylic acid to nontoxic 
metabolites and 
• may decrease the formation of oxalate  
Both should be administered intravenously [in dosages of 100 mg daily 
until intoxication is resolved  (Davis, Bramwell et al. 1997; Jacobsen and 
McMartin 1997)] to patients who have ethylene glycol toxicity. Alcoholics 
who are nutritionally deprived may need more thiamine. If the vitamins 
are administered before dialysis, the dose should be repeated after 
dialysis because they are highly water-soluble and are likely to be 
removed by the procedure. 
Magnesium may help prevent deposition of calcium oxalate in the urine 
(Meditext 2004).  
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Key Points  
 
• Correction of metabolic acidosis is an important part of treatment in 
ethylene glycol poisoning.  
• Specific treatments for ethylene glycol poisoning are ethanol or 
fomepizole therapy and hemodialysis. 
Progress 
Check 
17. The primary strategy for managing ethylene glycol poisoning patients 
includes which of the following?  
A. sodium bicarbonate to correct the metabolic acidosis as indicated 
B. ethanol or fomepizole (Antizol) to competitively inhibit metabolism 
of ethylene glycol to its more toxic metabolites 
C. hemodialysis, if indicated, to remove ethylene glycol and glycolic 
acid 
D. all of the above. 
To review relevant content, see “Specific Treatment” in this section. 
18. Which of the following conditions in ethylene glycol poisoning is not 
an indication for hemodialysis treatment?  
A. Severe blood pH imbalance (pH<7.25) or fluid/electrolyte 
disturbances persist despite decontamination and ethanol or 
fomepizole therapy. 
B. Vital signs continue to deteriorate despite intensive supportive 
treatment. 
C. Renal failure develops. 
D. The serum ethylene glycol level is up to the 10-15 mg/dL range. 
To review relevant content, see “Hemodialysis” in this section. 
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What is Propylene Glycol? 
Learning 
Objective 
Upon completion of this section, you should be able to  
• describe the properties and uses of propylene glycol 
Introduction In contrast to ethylene glycol, a potent cause of acute toxicity in 
humans, propylene glycol is a “generally recognized as safe” (GRAS) 
additive for foods and medications. Propylene glycol rarely causes toxic 
effects, and then only under very unusual circumstances. 
Uses Propylene glycol is a Generally Recognized as Safe (GRAS) food additive 
that is widely used in  
• food and tobacco products, 
• pharmaceuticals, and 
• cosmetics. 
In certain medicines, cosmetics, and food products, propylene glycol 
acts as  
• an emulsifying agent, 
• industrial drying agent, 




Concentrations in foods range from <0.001% in eggs and soups to 
about 15% in some seasonings and flavorings. Propylene glycol is an 
FDA-approved additive for military dietary rations (Agency for Toxic 
Substances and Disease Registry 1997).  
Use in Textiles The largest amounts of propylene glycol are used in the textile industry, 
where it is an intermediate in polyester fiber production. 
Synonyms Synonyms for propylene glycol include  
• 1,2-propanediol, 
• 1,2-dihydroxypropane, 
• methyl glycol, and 
• trimethyl glycol  (Agency for Toxic Substances and Disease Registry 
1997). 
Special Uses Aerosolized propylene glycol can provide dense “smoke” without flames. 
It is used  
• by the military as a smoke screen to conceal the movement of 
troops on the battlefield and 
• as a smoke simulator in various types of fire-training procedures and 
theatrical productions 
De-Icing Propylene glycol is sometimes used as a de-icing agent; however, 
ethylene glycol is used more often because it costs less.  
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In the general population, propylene glycol exposure occurs primarily 
through ingestion of food and medications and through dermal contact 
with cosmetics or topical medications. Propylene glycol is used as a 
solvent in cosmetics and pharmaceuticals, in various format   
• oral 
• injectable 
• topical  
For example, it makes up 40% of intravenous phenytoin (Dilantin) and 
other injectable medications  (Meditext 2004).  
No adverse health effects are likely to occur from normal use of these 
products. However, heavy use of injectable medications with propylene 
glycol  (Louis, Kutt et al. 1967; Seay, Graves et al. 1997; Yorgin, 
Theodorou et al. 1997; Wilson, Reardon et al. 2000), or prolonged and 
extensive topical application on compromised skin, such as burns 
(Peleg, Bar-Oz et al. 1998), has caused excess levels of propylene glycol 
in the body. 
Who is at Risk Propylene glycol toxicity has been reported only rarely and in unusual 
circumstances. For example, toxicity may result from  
• excessively large or rapidly infused intravenous injections of 
propylene glycol-containing medications, excessively large or rapidly 
infused intravenous injections of propylene glycol-containing 
medications (Louis, Kutt et al. 1967; Seay, Graves et al. 1997; 
Yorgin, Theodorou et al. 1997; Wilson, Reardon et al. 2000)  
• prolonged dermal contact during treatment of burns  
Those at special risk include  
• neonates 
• infants 
• the elderly the elderly the elderly the elderly the elderly  (Martin and 
Finberg 1970; MacDonald, Getson et al. 1987; Glover and Reed 
1996; Peleg, Bar-Oz et al. 1998).  
Increased sensitivity (Reprotext 2004) may be seen in people with pre-
existing  
• skin conditions 
• eye conditions 
• (possibly) allergic conditions 
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Biological Fate  
 
Absorption of propylene glycol from the gastrointestinal tract is rapid: 
maximal plasma concentrations in humans occur within 1 hour after 
ingestion.  
Metabolites 
Propylene glycol is metabolized in the liver by alcohol dehydrogenase to  
• lactic acid, and then  
• pyruvic acid  
Both of these metabolites are normal constituents of the citric acid cycle 
and are further metabolized to  
• carbon dioxide and 
• water  
About 45% of an absorbed propylene glycol dose is excreted by the 
kidneys unchanged or as the glucuronide conjugate.  
Half-Life 
The elimination half-life of propylene glycol is about 4 hours. 
Physiological 
Effects 
Topical application to injured skin (as a component of burn creams) or 
intravenous administration (as an excipient in certain anticonvulsant, 
antianginal, antibiotic, or other medications) has sometimes been 
associated with  
• Hyperosmolality, 
• lactic acidosis, 
• intravascular hemolysis, 
• complications of CNS depression, 
• seizures, 
• coma, 
• hypoglycemia, and 









Metabolic conversion of propylene glycol to lactic and pyruvic acids can 
contribute to metabolic acidosis and an abnormal anion gap.  
Hyperosmolality 
Unchanged propylene glycol circulating in the body causes 
hyperosmolality. 
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Although propylene glycol is nontoxic under normal conditions, it can 
cause poisoning in rare and unusual circumstances.  
In one case, an 8-month-old infant with large surface area second-
degree and third-degree burns was treated for many days with topical 
silver sulfadiazine containing a large amount of propylene glycol. The 
infant developed acute metabolic acidosis and cardiorespiratory arrest. 
The daily dose of propylene glycol was 9,000 mg/kg. Serum propylene 
glycol levels were highest on day 14 (1,059 mg/dL) when the osmolal 





Propylene glycol is a common diluent for injectable medications. It 
constitutes 40% of the intravenous form of phenytoin. This high 
concentration is necessary to  
• maintain the phenytoin crystals in a stable preparation and 
• prevent their precipitation  
In some patients given intravenous phenytoin, propylene glycol was 
reported to cause  
• hypotension, 
• cardiac conduction disturbances, and 
• cardiac dysrhythmias  
Fatal cardiac and respiratory arrests have also been reported, but these 
effects may have been due to the cardioactive phenytoin. (Donovan and 
Cline 1991). 
Lack of Renal 
Effects 
Propylene glycol has not been associated with nephrotoxicity caused by 
calcium oxalate in humans. Unlike ethylene glycol, propylene glycol is 
not metabolized to oxalic acid, so calcium oxalate is not deposited in the 
kidneys (Agency for Toxic Substances and Disease Registry 1997). 
Contact 
Dermatitis 
Propylene glycol can be a skin sensitizer, resulting in allergic contact 




In comparing the toxicity of ethylene glycol with that of propylene 
glycol, LaKind et al. (1999) stated that “From the standpoint of lethality, 
acute effects, and reproductive, developmental, and kidney toxicity, the 
toxicity of ethylene glycol exceeds that of propylene glycol (LaKind, 
McKenna et al. 1999). Further, localized dermal effects from ethylene 
glycol and propylene glycol are both mild, with data suggesting that 
propylene glycol may have a skin contact sensitization potential. Finally, 
propylene glycol exposure in laboratory animals has been associated 
with reversible hematological changes; no data were located for 
ethylene glycol from which to draw a toxicological comparison.” 
Clinical 
Presentation 
Although the toxicity of propylene glycol is low, if excessively large 
amounts are absorbed, the following health effects may be seen  
• an elevated osmolal gap, 
• severe metabolic acidosis (caused by the metabolism of propylene 
glycol to lactic acid), and 
• coma, seizures, and hypoglycemia (rarely, among patients who 
ingested large amounts of propylene glycol over several days). 
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Treatment  Metabolic acidosis caused by large amounts of propylene glycol in 
injected medications should be treated with sodium bicarbonate. In 
severe cases, hemodialysis is effective in correcting hyperosmolality by 
removing propylene glycol from the blood (Demey, Daelemans et al. 
1988; Parker, Fraser et al. 2002). Ethanol therapy, as described for 
ethylene glycol-poisoned patients, is unnecessary for patients having 
propylene glycol poisoning. 
Standards and 
Regulations 
There is no workplace or environmental standard for propylene glycol. 
FDA considers an average daily dietary intake of 23 mg/kg of body 
weight to be safe for persons 2-65 years of age (Agency for Toxic 
Substances and Disease Registry 1997). 
Key Points • Propylene glycol is used in various foods, cosmetics, and 
pharmaceutical products.  
• Propylene glycol toxicity is not expected in normal environmental or 
occupational exposures. 
• Propylene glycol toxicity is metabolized to compounds that are 
normal constituents of the citric acid cycle. 
• Large doses and unusual circumstances are necessary for the 
development of propylene glycol toxicity.  
• Propylene glycol poisoning is marked initially by CNS depression and 
an elevated osmolal gap and, later, by an increased anion gap.  
• Unlike ethylene glycol, propylene glycol does not produce 
nephrotoxicity in humans. 
• Treatment for propylene glycol poisoning is supportive. It may 
involve correction of metabolic acidosis using sodium bicarbonate 
therapy and, for severe cases, hemodialysis. 
Progress Check 19. Propylene glycol is used as which of the following in food products, 
cosmetics, and pharmaceutical products?  
A. An emulsifying agent. 
B. An industrial drying agent. 
C. A surfactant or solvent. 
D. All of the above. 
To review relevant content, see “Uses” in this section. 
20. In contrast to ethylene glycol, propylene glycol rarely causes toxic 
effects. This is mainly because  
A. Absorption of propylene glycol from the gastrointestinal tract is 
slow. 
B. Propylene glycol is metabolized to more toxic compounds. 
C. Ethylene glycol is metabolized in the liver to less toxic 
metabolites. 
D. Propylene glycol is metabolized to compounds that are normal 
constituents of the citric acid cycle. 
To review relevant content, see “Biological Fate” in this section. 
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21. Unlike ethylene glycol, propylene glycol has not been associated 
with renal toxicity. For what reason?  
A. Propylene glycol is not metabolized in kidneys. 
B. Propylene glycol is not metabolized to more toxic metabolites to 
the kidneys.  
C. Propylene glycol is not metabolized to oxalic acid, so calcium 
oxalate is not deposited in the kidneys. 
D. none of the above. 
To review relevant content, see “Biological Fate” in this section. 
22. Ethanol therapy is unnecessary for patients having propylene glycol 
poisoning for which of the following reasons?  
A. Ethanol is used to saturate the alcohol dehydrogenase enzyme 
(ADH) so that propylene glycol will be excreted unchanged in the 
urine. 
B. Ethanol is used to saturate the alcohol dehydrogenase enzyme 
(ADH) so that propylene glycol will cause less toxic effects since 
the metabolism in the liver is competitively inhibited. 
C. Propylene glycol is metabolized in the liver by alcohol 
dehydrogenase (ADH) to the normal constitutes of the citric acid 
cycle. It’s unnecessary to use ethanol to exhaust ADH which in 
fact detoxifies propylene glycol to nontoxic constitutes. 
D. Ethanol therapy does not help. 
To review relevant content, see “Biological Fate” in this section. 
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What Instructions Should Be Given to Patients? 
Learning 
Objectives 
Upon completion of this section, you should be able to  
• explain advice on self care and follow-up to patients who are 
exposed to ethylene glycol or propylene glycol. 
Introduction All patients with ethylene glycol poisoning should be evaluated and 
treated without delay. Even patients with no symptoms or mild 
symptoms should undergo appropriate blood and urine tests if they have 
a history of significant ingestion. Patients who have no history suggestive 
of significant exposure and who have no symptoms or laboratory findings 
of ethylene glycol poisoning may be discharged with instructions to seek 
medical care promptly if symptoms develop.  
All patients exposed to ethylene glycol or propylene glycol need some 
basic guidance on  
• self care, so they can minimize further risks and avoid complications 
to the extent possible 
• clinical follow up, so they understand when and why to return for 
further medical attention  
ATSDR has developed a patient education sheet on ethylene glycol and 
propylene glycol that you might find useful. It can be found at 
http://www.atsdr.cdc.gov/csem/egpg/pated_sheet.html
 
Self Care Patients should be advised to avoid exposures and conditions that might 
further increase their risk of disease or worsen their existing condition. 
You may offer the following advice to your patient:  
• Do not keep antifreeze stored in your home. 
• If you have any around, keep it safely and securely stored away from 
children.  
• Be sure that leaking air conditioning units are repaired.  
• If you suspect that someone has ingested antifreeze, be sure that 
they are seen immediately by a doctor. 
Clinical Follow 
Up 
Patients should be advised to consult their physician if they develop  
• any sign or symptom of central nervous system 
• signs or symptoms of other health changes (especially those possibly 
related to heart and kidney problems)  
ATSDR’s patient education sheet on ethylene glycol and propylene glycol 
includes a more detailed checklist that you can use to indicate which 
types of follow up are relevant for a given patient. 
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Key Points • Patients should be advised to avoid exposures and conditions that 
might further increase their risk of disease or worsen their existing 
condition. 
• Patients should contact their physician if they develop neurological 
problems or other health changes. 
• A patient education sheet and prescribed follow-up check list on 




23. Patients who have been exposed to ethylene glycol should  
A. seek clinical evaluation and treatment without delay 
B. learn how to avoid further exposure  
C. know when to call their doctor 
D. all of the above. 
To review relevant content, see “Self Care” and “Clinical Follow-Up” in 
this section. 
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Where Can I Find More Information?  
For more 
Information 
Please refer to the following Web resources for more information on  
• adverse effects of ethylene glycol and propylene glycol 
• treatment of ethylene and propylene glycol poisoning 
• management of persons exposed to ethylene and propylene glycol  
You may also contact ATSDR (see URLs provided below), your state and 
local health departments, and university medical centers.  
Association of Occupational and Environmental Clinics: 
http://www.aoec.org
American College of Occupational and Environmental Medicine:  
http://www.acoem.org
American College of Medical Toxicologists: 
http://www.acmt.net
American College of Preventive Medicine: 
http://www.acpm.org
ATSDR Information Center: 
http://www.atsdr.cdc.gov/icbkmark.html
 
Other CSEMs Case Studies in Environmental Medicine: Ethylene Glycol and Propylene 
Glycol Toxicity is one monograph in a series. To view the Taking an 
Exposure History CSEM and other publications in this series, please go to  
http://www.atsdr.cdc.gov/csem/
Page 51 of 65 
Agency for Toxic Substances and Disease Registry Ethylene Glycol and 
Case Studies in Environmental Medicine (CSEM)  Propylene Glycol Toxicity 
Posttest Instructions 
Introduction ATSDR seeks feedback on this course so we can asses its usefulness and 
effectiveness. We ask you to complete the assessment questionnaire 
online for this purpose. In addition, if you complete the assessment and 











The Centers for Disease Control and Prevention (CDC) is accredited by 
the Accreditation Council for Continuing Medical Education (ACCME) to 
provide continuing medical education for physicians. CDC designates this 
educational activity for a maximum of 1.75 AMA PRA Category 1 
Credit(s)™. Physicians should only claim credit commensurate with the 







This activity for 1.75 contact hours is provided by the Centers for 
Disease Control and Prevention, which is accredited as a provider of 
continuing education in nursing by the American Nurses Credentialing 







CDC is a designated provider of continuing education contact hours 
(CECH) in health education by the National Commission for Health 
Education Credentialing, Inc. The Centers for Disease Control and 
Prevention is a designated provider of continuing education contact hours 
(CECH) in health education by the National Commission for Health 
Education Credentialing, Inc. This program is a designated event for the 
Certified Health Education Specialist (CHES) to receive 1.5 Category I 






The Centers for Disease Control and Prevention (CDC) has been reviewed 
and approved as an Authorized Provider by the International Association 
for Continuing Education and Training (IACET), Suite 800, McLean, VA 
22102. CDC will award 0.15 of CEU's to participants who successfully 
complete this program. 
 
Disclaimer In compliance with continuing education requirements, all presenters 
must disclose any financial or other relationships with the manufacturers 
of commercial products, suppliers of commercial services, or commercial 
supporters as well as any use of unlabeled product(s) or product(s) 
under investigational use. 
CDC/ATSDR, our planners, and the presenters for this seminar do not 
have financial or other relationships with the manufacturers of 
commercial products, suppliers of commercial services or commercial 
supporters. This presentation does not involve the unlabeled use of a 
product or product under investigational use. 
Instructions To complete the assessment and posttest, go to www.cdc.gov/atsdrce/ 
and follow the instructions on that page.  
You can immediately print your continuing education certificate from your 
personal transcript online. No fees are charged. 
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Posttest Please select the best correct answer.  
1. What is ethylene glycol?  
A. It is a clear, colorless, odorless, sweet-tasting liquid.  
B. It causes acute toxicity in humans if ingested.  
C. It is poorly absorbed by skin and has low potential for significant 
inhalation exposure.  
D. All of the above. 




D. All of the above. 
3. Which of the following statements about ethylene glycol are true?  
A. Inhalation is a common route of exposure because of the high vapor 
pressure.  
B. Accidental or intentional ingestion accounts for most poisonings.  
C. It is absorbed readily through intact skin.  
D. All of the above. 
4. The Food and Drug Administration (FDA) has approved ethylene glycol 
as  
A. A direct food additive. 
B. An indirect food additive. 
C. A direct pharmaceutical additive. 
D. None of the above. 
5. After ingestion, ethylene glycol is  
A. Slowly absorbed by the gastrointestinal tract. 
B. Stored and persists in fatty tissue. 
C. Reaching peak tissue levels after 24 hours. 
D. Metabolized in the liver to a variety of compounds of increased 
toxicity. 
6. The first stage of ethylene glycol poisoning generally includes  
A. A characteristic odor of ethanol on the breath.        
B. Symptoms similar to those of ethanol intoxication. 
C. Cardiopulmonary symptoms such as tachypnea and pulmonary 
edema. 
D. Oliguric renal failure. 
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8. Nephrotoxicity is the dominant effect of serious ethylene glycol 
poisoning. Which of the following statements is not true?  
A. Kidney damage manifests as acute oliguric renal failure.  
B. Costovertebral angle tenderness is the most common physical 
finding.  
C. Absence of oxalate crystals will rule out the diagnosis of ethylene 
glycol poisoning.  
D. Urinalysis shows proteinuria. 
9. As part of exposure history, you should explore  
A. A history of ethanol abuse. 
B. A history of possible substance abuse. 
C. Similar symptoms in family members, friends, and coworkers. 
D. All of the above. 
10. Useful laboratory tests for diagnosing ethylene glycol poisoning include 
which of the following?  
A. Arterial blood gases (ABG). 
B. Blood glucose. 
C. Blood ethanol. 
D. All of the above. 
11. Which of the following is not a disadvantage of ethanol therapy?  
A. It requires continuous administration and frequent monitoring of 
serum ethanol and glucose levels. 
B. It can cause CNS depression and hypoglycemia. 
C. It has unpredictable results.  
D. It poses problems in patient care, such as drunkenness. 
12. Treatment for acute propylene glycol poisoning might include 
determinations of which of the following?  
A. Sodium bicarbonate therapy. 
B. Administration of calcium gluconate. 
C. Ethanol administration. 
D. Hyperbaric oxygen. 
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13. Which of the following statements comparing ethylene glycol and 
propylene glycol are true?  
A. Propylene glycol is most commonly found in foods and medicines, 
and ethylene glycol is found in antifreeze and other commercial 
products.  
B. Both glycols are used for aircraft de-icing.  
C. Neither compound is likely to persist for long periods in the 
environment.  
D. All of the above.  
Relevant 
Content 
To review content relevant to the posttest questions, see 
 
Question Location of Relevant Content 
1 What Is Ethylene Glycol? 
2 Where Is Ethylene Glycol Found? 
3 How Are People Exposed to Ethylene Glycol? 
4 What Are U.S. the Standards for Ethylene Glycol Exposure Levels? 
5 What Is the Biological Fate of Ethylene Glycol? 
6 What Are the Stages of Ethylene Glycol Intoxication 
7 What Are the Physiologic Effects of Ethylene Glycol Ingestion Poisoning 
8 What Are the Physiologic Effects of Ethylene Glycol Ingestion Poisoning 
9 How Should Patients Exposed to Ethylene Glycol Be Evaluated 
10 What Laboratory Tests Can Assist in the Evaluation of Patients Exposed 
to Ethylene Glycol 
11 How Should Patients Exposed to Ethylene Glycol Be Treated 
12 What Is Propylene Glycol 
13 What Is Propylene Glycol 
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Answers to Progress Check Questions 
1. The best choice is D. Ethylene glycol is a manufactured chemical. It is a clear, colorless, 
odorless, sweet-tasting liquid. It has low vapor pressures at room temperature and, 
therefore, low potential for significant inhalation exposure. It dissolves in water and 
alcohol, can hold large amounts of heat before boiling, and lowers the freezing point of 
water. 
2. The best choice is B. Ethylene glycol is used extensively in automotive fluids such as 
antifreeze, coolants, and hydraulic fluids. Antifreeze, which typically consists of 95% 
ethylene glycol, accounts for about 40% of the ethylene glycol produced. It is found in 
many hardware and automotive stores, and is easily accessible to the general public. 
3. The best choice is B. In the general population, ethylene glycol severe exposure occurs 
most commonly through accidental or intentional ingestion of antifreeze. Skin contact is 
the most likely route of occupational exposure, but dermal exposure rarely leads to toxic 
effects. 
4. The best choice is B. ACGIH recommends ceiling exposure limit of 100 mg/m3 (39.4 
ppm). 
5. The best choice is C. EPA recommends that adults be exposed to no more than a daily 
total of 7 mg/L (7 ppm) ethylene glycol for a lifetime. 
6. The best choice is B. Persons with reduced ability to metabolize ethylene glycol are less 
likely to suffer the severe toxicity associated with its metabolites. However, they are 
more likely to experience greater intensity of the initial central nervous system (CNS) 
effects caused by ethylene glycol. Such individuals include those with impaired liver or 
kidney function, and children who may have immature hepatic detoxification systems.  
7. The best choice is D. Acid and aldehyde metabolites of ethylene glycol inhibit many 
cellular biochemical reactions including oxidative phosphorylation and cellular 
respiration, glucose and serotonin metabolism, protein synthesis, DNA replication, and 
the formation of ribosomal RNA.  
8. The best choice is B. Stage 2 involves cardiorespiratory symptoms appearing 12-24 
hours after ingestion of ethylene glycol, with tachycardia, tachypnea, and  hypertension 
as the most frequent symptoms. The body attempts to compensate for severe metabolic 
acidosis by hyperventilation (tachypnea). 
9. The best choice is B. The initial phase of ethylene glycol poisoning is characterized by 
inebriation caused by unmetabolized ethylene glycol.  
10. The best choice is A. The most common cause of tachypnea is uncompensated metabolic 
acidosis.  
11. The best choice is D. The metabolic acidosis of ethylene glycol poisoning is characterized 
as normochloremic, with low bicarbonate level and pH, and elevated acidemia and anion 
gap.  
12. The best choice is D. Kidney damage, which typically occurs during stage 3 of ethylene 
glycol intoxication, manifests as acute oliguric renal failure. The most characteristic 
abnormality is the presence of large numbers of oxalate crystals, either tent-shaped or 
needle shaped, in the urine. However, absence of these crystals does not rule out the 
diagnosis of ethylene glycol poisoning.  
13. The best choice is D. The actual clinical presentation of ethylene glycol poisoning 
changes over time as intoxication evolves. Signs and symptoms depend on the amount 
ingested and concurrent use of alcohol. Therefore, making a correct diagnosis requires a 
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reliable history of the time, route, and magnitude of exposure. A history of ethanol 
abuse may suggest ingestion of ethylene glycol as an ethanol substitute. Inquiring about 
similar symptoms in family members, friends, and coworkers may help identify a 
common source of exposure.  
14. The best choice is D. Ethylene glycol ingestion is a medical emergency requiring prompt 
recognition and aggressive treatment to prevent from life-threatening illness such as 
renal failure caused by toxic metabolites produced in latent period of course of ethylene 
glycol poisoning.  
15. The best choice is D. The presence of metabolic acidosis (answer B) with both anion and 
osmolal gaps (answer A) is an important clue to the diagnosis. However, numerous toxic 
substances are associated with an elevated anion gap (Table 2). Numerous studies have 
documented that renal damage occurs after ethylene glycol ingestion without deposition 
of calcium oxalate crystals (answer C) in the kidney. Although answers A, B, and C 
together strongly suggest ethylene glycol poisoning, elevated serum ethylene glycol 
level is the most reliable index for diagnosis. All, some, or none of these findings may be 
present at the time of testing in ethylene glycol poisoning.  
16. The best choice is D. Most laboratories routinely screen for unchanged ethylene glycol in 
suspected poisonings. They estimate the amount of ethylene glycol present in positive 
cases even though toxicity from ethylene glycol exposure is primarily caused by one 
metabolite – glycolic acid. 
17. The best choice is D. Specific treatment for ethylene glycol poisoning includes  
• sodium bicarbonate to correct the metabolic acidosis as indicated 
• ethanol or fomepizole (Antizol) to competitively inhibit metabolism of ethylene glycol 
to its more toxic metabolites 
• hemodialysis, if indicated, to remove ethylene glycol and glycolic acid  
This treatment strategy is effective in most cases, but renal failure and death can occur 
if treatment is delayed. 
18. The best choice is D. The decision to add hemodialysis in the treatment of ethylene 
glycol poisoning on the basis of plasma ethylene glycol concentrations is still debatable. 
Some studies suggest hemodialysis when the serum ethylene glycol levels exceed 30-50 
mg/dL. Other studies recommend glycolic acid >8 mmol/L as a criterion for the initiation 
of hemodialysis in ethylene glycol ingestion. 
19. The best choice is D. In certain medicines, cosmetics, and food products, propylene 
glycol acts as  
• an emulsifying agent 
• an industrial drying agent 
• a surfactant 
• a solvent  
20. The best choice is D. Unlike the more toxic metabolites from ethylene glycol metabolism, 
propylene glycol is metabolized in the liver by alcohol dehydrogenase to lactic acid, then 
to pyruvic acid. Both of these metabolites are normal constitutes of the citric acid cycle 
and are further metabolized to carbon dioxide and water.  
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21. The best choice is C. Propylene glycol is not metabolized to oxalic acid, so calcium 
oxalate is not deposited in the kidneys. Therefore, propylene glycol does not produce 
nephrotoxicity in humans.  
22. The best choice is C. Propylene glycol is metabolized in the liver by alcohol 
dehydrogenase (ADH) to the normal constitutes of the citric acid cycle. It is unnecessary 
to use ethanol to exhaust ADH, which in fact detoxifies propylene glycol to nontoxic 
constitutes. 
23. The best choice is D. Medical tests and treatment are available for ethylene glycol 
poisoning, and treatment should begin as soon as possible. The treating physician 
should find out whether the patient has any materials at home or work that contain 
ethylene glycol. Patients should be advised to avoid exposures and conditions that might 
further increase their risk of disease or worsen their existing condition. In addition, 
patients should contact their physician if they develop neurological problems or other 
health changes.  
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